Mirati Therapeutics Inc. buy DomRuinart
Start price
28.06.21
/
50%
€146.55
Target price
28.06.22
€200.00
Performance (%)
-3.62%
End price
12.07.21
€141.25
Summary
This prediction ended on 12.07.21 with a price of €141.25. With a performance of -3.62%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Mirati Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 0.383% | -1.593% | 16.084% | 14.286% |
iShares Nasdaq 100 | 1.543% | 7.530% | 38.446% | 53.091% |
iShares Nikkei 225® | 2.596% | 4.525% | 14.539% | 9.353% |
iShares S&P 500 | 0.573% | 4.229% | 30.110% | 45.397% |
According to DomRuinart what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy mit Kursziel 200,0
In the thread Trading Mirati Therapeutics Inc.
Buy beendet
Stopped prediction by DomRuinart for Mirati Therapeutics Inc.
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€138.00
16.06.21
16.06.21
€200.00
16.06.22
16.06.22
6.20%
28.06.21
28.06.21
Could be worthwhile Investment >10% per year